{"id":8561,"date":"2025-09-11T11:33:56","date_gmt":"2025-09-11T08:33:56","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8561"},"modified":"2025-09-11T11:33:56","modified_gmt":"2025-09-11T08:33:56","slug":"advances-in-electrosurgical-techniques-for-transcatheter-valve-therapies","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/advances-in-electrosurgical-techniques-for-transcatheter-valve-therapies\/","title":{"rendered":"Advances in Electrosurgical Techniques for Transcatheter Valve Therapies"},"content":{"rendered":"<div>Advances in Electrosurgical Techniques for Transcatheter Valve Therapies<\/div>\n<div><\/div>\n<div>Source: Medical News, September 6, 2025 \u2013 based on Cleveland Clinic\u2019s official medical insights platform \u2013 Consult QD<\/div>\n<div><\/div>\n<div>1. Background &amp; Impact<\/div>\n<div><span> \u2022 Thousands of patients once ineligible for surgery or transcatheter therapy can now be treated.<\/span><\/div>\n<div><span> \u2022 Electrosurgical techniques turn \u201cno-option\u201d cases into candidates for TAVR (aortic) or TMVR (mitral).<\/span><\/div>\n<div><span> \u2022 These are \u201cenabling technologies\u201d that solve anatomical barriers which would otherwise make procedures impossible or extremely high risk.<\/span><\/div>\n<div><\/div>\n<div>2. Key Techniques &amp; When the Danger Is Highest<\/div>\n<div><span> \u2022 Transcaval<\/span><\/div>\n<div><span> \u2022 Creates a controlled channel from vena cava \u2192 aorta to deliver TAVR when femoral\/arterial access is unsuitable.<\/span><\/div>\n<div><\/div>\n<div>* BASILICA<\/div>\n<div><span> \u2022 Deliberately cuts one aortic leaflet (native or bioprosthetic) before implanting a new valve.<\/span><\/div>\n<div><span> \u2022 Prevents coronary obstruction \u2014 a rare but lethal complication with ~50% mortality.<\/span><\/div>\n<div><span> \u2022 No danger of regurgitation, because the new transcatheter valve immediately takes over sealing and function.<\/span><\/div>\n<div><span> \u2022 Risk scenario: when the aortic leaflets are bulky, long, or bioprosthetic, they may obstruct the coronary ostia during TAVR if not lacerated<\/span><\/div>\n<div><\/div>\n<div>* LAMPOON<\/div>\n<div><span> \u2022 Cuts the anterior mitral leaflet before TMVR to prevent LVOT obstruction.<\/span><\/div>\n<div><span> \u2022 Risk scenario: patients with a small LV cavity or an elongated anterior mitral leaflet that could block the LV outflow tract after valve implantation \u2014 a complication that can be rapidly fatal.<\/span><\/div>\n<div><\/div>\n<div>* SESAME<\/div>\n<div><span> \u2022 Electrosurgical thinning or splitting of a thickened interventricular septum.<\/span><\/div>\n<div><span> \u2022 Risk scenario: hypertrophic cardiomyopathy (HCM), bulky septum, or narrow LVOT that would make TMVR unsafe or impossible without septal modification.<\/span><\/div>\n<div><\/div>\n<div>3. Clinical Adoption<\/div>\n<div><span> \u2022 BASILICA &amp; Transcaval: performed in thousands of patients worldwide.<\/span><\/div>\n<div><span> \u2022 LAMPOON: approaching 1,000 cases globally.<\/span><\/div>\n<div><span> \u2022 Rapid uptake through training workshops, registries, and social media (many operators learned via published cases or videos).<\/span><\/div>\n<div><\/div>\n<div>4. Benefits<\/div>\n<div><span> \u2022 Enable treatment for high-risk or previously inoperable patients.<\/span><\/div>\n<div><span> \u2022 Prevent catastrophic complications:<\/span><\/div>\n<div><span> \u2022 Coronary obstruction during TAVR.<\/span><\/div>\n<div><span> \u2022 LVOT obstruction during TMVR.<\/span><\/div>\n<div><span> \u2022 Expand the safe use of TAVR and TMVR to anatomies once considered prohibitive.<\/span><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/consultqd.clevelandclinic.org\/a-new-option-for-valve-in-valve-procedures-requiring-prosthetic-leaflet-modification\">https:\/\/consultqd.clevelandclinic.org\/a-new-option-for-valve-in-valve-procedures-requiring-prosthetic-leaflet-modification<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Advances in Electrosurgical Techniques for Transcatheter Valve Therapies Source: Medical News, September 6, 2025 \u2013 based on Cleveland Clinic\u2019s official medical insights platform \u2013 Consult QD 1. Background &amp; Impact \u2022 Thousands of patients once ineligible for surgery or transcatheter therapy can now be treated. \u2022 Electrosurgical techniques turn \u201cno-option\u201d cases into candidates for TAVR [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8561","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8561"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8561\/revisions"}],"predecessor-version":[{"id":8562,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8561\/revisions\/8562"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}